NLR、PLR、LMR及PNI对晚期肝细胞癌靶向联合免疫治疗临床疗效 及预后的预测价值.Published in:Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 3, p. 309, doi. 10.3872/j.issn.1007-385x.2025.03.011By:刘全义;杨逸鑫;徐磊;古云;沈磊Publication type:Article